New MS Drug Reducing Patient Lapses
An updated version of an old drug for multiple sclerosis is reducing patient lapses with fewer doses.
Researchers at Johns Hopkins University found the improved drug known as  pegylated interferon beta can be injected every two weeks instead of every other day and get the same results. Â
They also found fewer MS patients are developing antibodies against the drug which reduces its effectiveness.
